共 50 条
- [33] COULD THE PHARMACOLOGICAL DIFFERENCES OBSERVED BETWEEN ANGIOTENSIN-II ANTAGONISTS AND INHIBITORS OF ANGIOTENSIN CONVERTING ENZYME BE CLINICALLY BENEFICIAL PHARMACOLOGY & TOXICOLOGY, 1992, 71 (04): : 241 - 249
- [34] ANALYSIS OF THE ACTIVE CONFORMATION OF ANGIOTENSIN-II - A COMPARISON OF AII-ANTAGONISTS AND NONPEPTIDE AII-ANTAGONISTS PEPTIDE RESEARCH, 1992, 5 (02): : 102 - 105
- [39] INHIBITION OF ANGIOTENSIN-CONVERTING ENZYME AND ATTENUATION OF MYOCARDIAL FIBROSIS BY LISINOPRIL IN RATS RECEIVING ANGIOTENSIN-II JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1995, 126 (01): : 95 - 101
- [40] EVALUATION OF A NOVEL SERIES OF IMIDAZOLE ANGIOTENSIN-II (AII) RECEPTOR ANTAGONISTS FASEB JOURNAL, 1992, 6 (05): : A1871 - A1871